Although monoclonality by molecular analysis may help diagnose cutaneous lymphoma, its presence does not necessarily mean a malignancy, nor does its absence rule it out.

Targeting mutations in genes involved in the MYC, BCL6, NF-κB, and JAK-STAT signaling pathways, among others, may assist and serve as critical ancillary tests when working-up CTCL and CBCL.